-
Mashup Score: 0Glucagon-Like Peptide-1 Receptor Agonists: A New Frontier in Atrial Fibrillation Treatment - 5 day(s) ago
Linda Moulton, RN, MS, reviews the characteristics of epicardial adipose tissue, its impact on atrial fibrillation, the action of glucagon-like peptide-1 receptor agonists to alter that fat, and drug side effects.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0HeartCorps: Public Health AmeriCorps at the AHA - 5 day(s) ago
Over our 100-year history, we’ve been fighting heart disease and stroke, striving to save and improve lives. A shared focus on cardiovascular health unites our more than 32 million volunteers, supporters and donors as well as our more than 2,800 employees. Learn more about our lifesaving history. Heart disease is the No. 1 killer worldwide, and stroke ranks second globally. Even when those conditions don’ t result in death, they cause disability and diminish quality of life. We want to see a world free
Source: www.heart.orgCategories: General Medicine News, Cardiology News and JournTweet-
Help build health equity in rural America and get valuable public health experience as a HeartCorps Service Member. If you’re a recent college graduate or looking for a career change, this is a valuable opportunity to learn while doing and give back. https://t.co/3u0TVRA8Wd. https://t.co/GheYj8APSO
-
-
Mashup Score: 0Prognostic importance of ischemic heart disease among patients with atrial fibrillation undergoing catheter ablation - 5 day(s) ago
Ischemic heart disease (IHD) has been linked to an increased risk of atrial fibrillation (AF). However, data are sparse regarding the role of IHD in AF recurrence after catheter ablation.
Source: www.heartrhythmjournal.comCategories: General Medicine News, Cardiology News and JournTweet-
Prognostic importance of ischemic heart disease among patients with atrial fibrillation undergoing catheter ablation https://t.co/9B7hwHofW1
-
-
Mashup Score: 0Challenging Retrieval of a Dislodged Leadless Pacemaker from the Left Pulmonary Artery in an Elderly Patient - 5 day(s) ago
Micra™ AV leadless pacemakers (Micra, Medtronic Japan) offer significant benefits, even in elderly patients1. However, device dislodgement into difficult-to-reach areas such as the left pulmonary artery (LPA) requires advanced techniques and appropriate tools for retrieval2.
Source: www.heartrhythmcasereports.comCategories: General Medicine News, Cardiology News and JournTweet-
Challenging Retrieval of a Dislodged Leadless Pacemaker from the Left Pulmonary Artery in an Elderly Patient https://t.co/lrGiTKqpjO https://t.co/HjtWfDd5kR
-
-
Mashup Score: 5
Page Not Found We’re sorry, but this page is not available. You may also be interested in: Becoming a Member Becoming a Science Volunteer Meetings and Conferences Research Programs Science News AHA Professional Heart Daily Job Board
Source: professional.heart.orgCategories: General Medicine News, Cardiology News and JournTweet-
Cardiovascular-Kidney-Metabolic Syndrome: a health disorder due to connections among obesity, diabetes, chronic kidney disease & CVD. 📖 @CircAHA ✍️ Chiadi E. Ndumele, MD, PhD, MHS & @RangaswJ More on defining, screening, and treating this syndrome: https://t.co/Tm2DlaXMaE https://t.co/kpO9W3Db1S
-
-
Mashup Score: 7Texas Heart Institute Journal - 5 day(s) ago
Impact of Atrial Fibrillation Type on Outcomes of Transcatheter Aortic Valve Replacement for Aortic Stenosis: A Single-Center Analysis
Source: thij.kglmeridian.comCategories: General Medicine News, Cardiology News and JournTweet-
📓 New From #THIJournal In a single-center study from Yamashita, et al., nonparoxysmal AF was associated with higher risk of periprocedural and all-cause mortality in patients undergoing #TAVR for severe aortic stenosis, while paroxysmal AF was not: https://t.co/Ns11So0ZnH https://t.co/FBqkszDx0M
-
-
Mashup Score: 0
About NLA Scientific Sessions 2024 Mark your calendars for June 2024 and join us at #NLASessions in the vibrant city of Las Vegas, NV. Dive deep into the nuances of lipidology, from uncovering clinical insights to forging new professional bonds. Our gathering is where the entire lipidology community converges. The agenda is packed with sessions that delve into the intricacies
Source: www.lipid.orgCategories: General Medicine News, Cardiology News and JournTweet-
🌟 Exciting News! 🌟 Join us at the 2024 #NLASessions in Las Vegas next June! 🎉 Registration is NOW OPEN! 🎊 Don't miss out on the latest lipid research and dive into the intricacies of lipid management. Secure your spot today! 📚👥 https://t.co/BGLXqmyFOl https://t.co/MOTYdQA2xQ
-
-
Mashup Score: 1Video - Walking, Moving More May Lower Risk of Cardiovascular Death for Women with Cancer History - 5 day(s) ago
Walking, moving more may lower risk of cardiovascular death for women with cancer history – Video with music and text Transcript (doc) | Graphic cover (jpg) | News Release Video copyright American Heart Association 2025 Song: Relaxing Light/ Royalty Free
Source: newsroom.heart.orgCategories: General Medicine News, Cardiology News and JournTweet-
Video - Walking, Moving More May Lower Risk of Cardiovascular Death for Women with Cancer History #EPILifestyle25 #AHAHeartNewsVideos https://t.co/IMziCdHs7r
-
-
Mashup Score: 0Dr. Diaz EPI25 060 find ways to move more - 5 day(s) ago
American Heart Association volunteer expert: Keith Diaz, Ph.D., the Florence Irving Associate Professor of Behavioral Medicine at Columbia University Medical Center in New York, a certified exercise physiologist and a member of the American Heart Association’s Physical Activity Science Committee. Transcript (txt) News release copyright American Heart Association
Source: newsroom.heart.orgCategories: General Medicine News, Cardiology News and JournTweet-
VIDEO: American Heart Association volunteer expert, Keith Diaz, Ph.D.shares simple strategies that you can use to incorporate more movement throughout your day after new research shows benefits for women who've had cancer. #EPILifestyle25 https://t.co/E0qmWkBWk1
-
-
Mashup Score: 1
The DCB looks good in select cases, but given its high price tag, exactly when to use it is still up for discussion, say experts.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet-
AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years https://t.co/D8vdPfRMwj https://t.co/q5aNvYp6KB
-
New on the #AFib Topic Center! 👉 "Glucagon-Like Peptide-1 Receptor Agonists: A New Frontier in Atrial Fibrillation Treatment" Explore the latest research on this emerging therapy and its potential to reshape AF management. 🫀 https://t.co/VrzV5EpkPZ https://t.co/gAEeSWw4du